Skip to main content Back to Top


Guidelines Available on Nonemergency Phenytoin Products

Cheryl A. Thompson

To promote the safe, cost-efficient use of injectable phenytoin and fosphenytoin, an expert panel consisting mostly of pharmacists has developed an algorithm for the nonemergency treatment of seizures with these drugs.

The algorithm, published in the Dec. 13/27 issue of Archives of Internal Medicine, provides step-by-step guidance in selecting which of the two products to use, whether to inject it intravenously or intramuscularly, and how to monitor the patient.